When a Fortune 500 CEO is diagnosed with cancer, has a stroke at 58, or steps down due to burnout, the organizational impact is immediate and severe — stock price volatility, leadership vacuum, strategic disruption, and stakeholder anxiety. Yet most boards treat executive health as a personal matter rather than a governance responsibility.
Dr. Paul Kilgore — a physician-epidemiologist, former CDC Disease Detective, and longevity medicine physician — argues that this is a structural blind spot in corporate governance. Drawing on 36 years of clinical experience, epidemiological risk assessment expertise, and his work building physician-designed health tools used by individuals and organizations, he presents the case for treating executive health as a formal risk category — alongside cybersecurity, regulatory compliance, and financial controls.
This session covers the epidemiology of executive health events (what actually happens, how often, and at what cost), the legal and fiduciary dimensions of leadership health risk, what leading organizations are doing to formalize executive health oversight, and how boards can implement health risk governance without violating privacy or overstepping boundaries. Dr. Kilgore introduces a governance-ready executive health framework that balances organizational interest with individual autonomy — providing boards with a structured approach to a risk they have historically ignored.
Attendees leave with a clear framework for adding executive health to their governance agenda and the language to champion it at the board level.

Format: Board briefing or governance conference keynote. Duration: 30–45 minutes. Target audience: Board directors, corporate governance professionals, general counsel, institutional investors, private equity partners, executive compensation consultants, corporate secretaries. Confidential delivery format available. AV needs: screen, microphone, HDMI.